Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy

Rory M. Shallis , Maximilian Stahl , Wei Wei, Pau Montesinos , Etienne Lengline, Judith Neukirchen, Vijaya R. Bhatt, Mikkael A. Sekeres, Amir T. Fathi, Heiko Konig, Selina Luger, Irum Khan, Gail J. Roboz, Thomas Cluzeau, David Mart ınez-Cuadron, Emmanuel Raffoux, Ulrich Germing, Jayadev Manikkam Umakanthan, Sudipto Mukhereje, Andrew M. Brunner, Adam Miller, Christine M. McMahon , Ellen K. Ritchie, Rebeca Rodr ıguez-Veiga, Rapha€el Itzykson, Blanca Boluda , Florence Rabian, Mar Tormo , Evelyn Acu~ na-Cruz, Emma Rabinovich, Brendan Yoo, Isabel Cano, Nikolai A. Podoltsev, Jan Philipp Bewersdorf , Steven Gore and Amer M. Zeidan Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA; CIBERONC, Instituto Carlos III, Madrid, Spain; Hematology Department, Saint-Louis Hospital AP-HP, Paris, France; Department of Hematology, Oncology and Clinical Immunology, HeinrichHeine-University Duesseldorf, Duesseldorf, Germany; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA; Leukemia Program, Cleveland Clinic, Cleveland, OH, USA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA; Indiana University Simon Cancer Center, Indianapolis, IN, USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; University of Illinois Cancer Center, Chicago, IL, USA; Weill Cornell Medicine, The New York Presbyterian Hospital, New York, NY, USA; CHU of Nice, Hematology Department, Cote d’Azur University, Nice, France; University of North Carolina Physician Network, Rocky Mount, NC, USA; University Clinical Hospital, INCLIVA, Valencia, Spain